Skip to main content
Fig. 4 | Journal of Experimental & Clinical Cancer Research

Fig. 4

From: Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?

Fig. 4

GB-targeted migration of MSCs after intranasal administration. a Schematic representation of the experimental model. MSCs were administered via the nasal cavity using a pipet tip. After passing the olfactory epithelium (brown), MSCs enter the brain and migrate towards the tumor. b Fluorescence microscopy images of tissue sections after the intranasal injection of MSCs into U87MG tumor-bearing mice. Three days (D15) and seven days (D19) after the intranasal administration of MSCs, the MSCs had migrated and were located within the tumor mass. MSCs were detected by red fluorescent labeling of the Y-chromosome. Nuclei were stained with DAPI. Scale bars = 100 μm. c Quantification of MSCs in the U87MG tumor three and seven days after intranasal administration. Results are expressed as the mean number of Y+ MSCs per mm2 ± SEM (*p < 0.05, versus the number of Y+ MSCs observed at day 15)

Back to article page